Skip to main content
SHINIL PHARMACEUTICAL CO., LTD. logo

SHINIL PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 012790 ISIN · KR7012790002 KO Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2020-07-24 Major Shareholding Noti…
Country KR South Korea
Listing KO 012790

About SHINIL PHARMACEUTICAL CO., LTD.

https://shinilpharma.com/

SHINIL PHARMACEUTICAL CO., LTD. is a drug manufacturing company that develops, produces, and sells a diverse range of pharmaceutical products. The company's portfolio encompasses various therapeutic areas, including vitamins, mineral supplements, anti-inflammatory enzymes, antihistamines, appetite stimulants, and treatments for liver disease. Its product offerings also include topical medications such as gels and medicated plasters. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (buy/sell/gift), and the relationship between the reporter and special related parties. This corresponds to the 'Major Shareholding Notification' category.
2020-07-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of an individual (Park Jong-chang) who is an executive at Shinil Pharmaceutical. This type of filing is specifically categorized as a Director's Dealing (insider trading/shareholding report).
2020-07-23 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease in holdings by a major shareholder) and is filed with the Financial Supervisory Service (FSS). This falls under the category of Major Shareholding Notification.
2020-07-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (acquisitions/disposals), and the purpose of holding (simple investment) for a specific individual and their special relations regarding Shinil Pharmaceutical Co., Ltd. This falls under the category of Major Shareholding Notification.
2020-06-25 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Sinil Pharmaceutical Co., Ltd. for the first quarter of 2020 (period ending 2020.03.31). It contains detailed financial data, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or on-market purchase) by a company director/major shareholder (Hong Seong-so) of Shinil Pharmaceutical Co., Ltd. This type of filing is a standard disclosure for insider trading/shareholding changes by company executives, which corresponds to the 'Director's Dealing' category.
2020-03-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.